| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |